ADMELOG 100 U/mL
insulin lispro · INJECTION, SOLUTION · Sanofi-Aventis U.S. LLC
No Recall History
Plain English
ADMELOG is a injection, solution containing insulin lispro at 100 U/mL, taken intravenous. Manufactured by Sanofi-Aventis U.S. LLC.
Key Facts
- Brand Name
- ADMELOG
- Generic Name
- insulin lispro
- NDC Code (Product)
0024-5924- Manufacturer
- Sanofi-Aventis U.S. LLC
- Strength
- 100 U/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA209196
- Drug Class
- Insulin Analog [EPC]
- Marketing Start
- 12/11/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is ADMELOG used for?
ADMELOG contains insulin lispro. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is ADMELOG a controlled substance?
ADMELOG is not classified as a controlled substance by the DEA.
What is the generic name for ADMELOG?
The generic name for ADMELOG is insulin lispro. There are 12 other brand versions of insulin lispro.
What is the NDC code for ADMELOG 100 U/mL?
The NDC (National Drug Code) for ADMELOG 100 U/mL is 0024-5924, listed by Sanofi-Aventis U.S. LLC.
Other Insulin Brands
See all →- Humalog100 [iU]/mL0002-7510
- Humalog Junior KwikPen100 [iU]/mL0002-7714
- LYUMJEV KwikPen200 [iU]/mL0002-8228
- Humalog KwikPen100 [iU]/mL0002-8799
- Humalog100 [iU]/mL0002-7516
- Humalog Tempo Pen100 [iU]/mL0002-8213
- Insulin Lispro100 [iU]/mL50090-5391
- LYUMJEV100 [iU]/mL50090-7433
- Humalog KwikPen200 [iU]/mL0002-7712
- LYUMJEV100 [iU]/mL0002-7728
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)